GoHealth Reports Disappointing FY Results, Shares Drop
- Disappointing Earnings: GoHealth's FY GAAP EPS of -$20.17 misses expectations by $0.08, indicating significant challenges in profitability that may undermine investor confidence.
- Revenue Decline: The reported revenue of $361.84 million represents a 54.7% year-over-year decline and falls short of the anticipated $437.84 million, highlighting severe pressures on the company's business model that could hinder future growth.
- Stock Price Reaction: Following the earnings report, GoHealth's shares fell 4.65% in after-hours trading, reflecting market disappointment with its financial performance, which may impact the company's future financing capabilities.
- Uncertain Market Outlook: With both revenue and profitability declining, GoHealth may need to reassess its future strategic direction to address challenges posed by intensified industry competition and shifting market demands.
Trade with 70% Backtested Accuracy
Analyst Views on GOCO
About GOCO
About the author
GoHealth Reports Disappointing FY Results, Shares Drop
- Disappointing Earnings: GoHealth's FY GAAP EPS of -$20.17 misses expectations by $0.08, indicating significant challenges in profitability that may undermine investor confidence.
- Revenue Decline: The reported revenue of $361.84 million represents a 54.7% year-over-year decline and falls short of the anticipated $437.84 million, highlighting severe pressures on the company's business model that could hinder future growth.
- Stock Price Reaction: Following the earnings report, GoHealth's shares fell 4.65% in after-hours trading, reflecting market disappointment with its financial performance, which may impact the company's future financing capabilities.
- Uncertain Market Outlook: With both revenue and profitability declining, GoHealth may need to reassess its future strategic direction to address challenges posed by intensified industry competition and shifting market demands.
GoHealth (GOCO) Announces Q3 Loss, Falls Short of Revenue Projections
Quarterly Performance: GoHealth reported a quarterly loss of $0.19 per share, significantly better than the expected loss of $2.06, marking a 90.78% earnings surprise. However, revenues of $34.19 million fell short of estimates by 67.05%.
Stock Performance: GoHealth shares have declined approximately 74.3% year-to-date, contrasting with a 16.5% gain in the S&P 500, raising concerns about the company's future stock performance.
Earnings Outlook: The current consensus EPS estimate for the upcoming quarter is $1.92, with revenues projected at $380.13 million. The stock holds a Zacks Rank #3 (Hold), indicating expected performance in line with the market.
Industry Context: The Insurance - Life Insurance industry is currently in the top 20% of Zacks-ranked industries, suggesting that broader industry trends could significantly influence GoHealth's stock performance moving forward.
Brighthouse Financial (BHF) Rises 27.2%: Is There More Growth Potential for the Stock?
Brighthouse Financial Stock Surge: Brighthouse Financial (BHF) shares surged 27.2% to $57.59, driven by acquisition news from Aquarian Holdings and increased trading volume, contrasting with a 2.5% loss over the past month.
Growth and Earnings Outlook: The company is focusing on enhancing its life insurance and annuity products, with expected quarterly earnings of $5.06 per share, reflecting a 26.8% year-over-year increase, and a revenue forecast of $2.25 billion, up 3.3% from last year.
5 Financial Stocks Face Challenges in Growth, Underperforming Compared to Sector Rivals
Weak Growth in Financial Stocks: Several financial sector stocks, including DeFi Technologies Inc., Pathfinder Bancorp Inc., and GoHealth Inc., are struggling with low growth in revenue and earnings, placing them among the weakest performers in their category.
Significant Declines Noted: DeFi Technologies saw a drastic drop in its growth ranking from 62.95 to 9.98, while Pathfinder Bancorp and GoHealth also experienced severe declines, indicating ongoing challenges in sustaining growth.
Performance Overview: Carver Bancorp and LM Funding America showed slight improvements but remain in the lowest growth percentiles, with both companies experiencing significant year-to-date stock price declines.
Investor Implications: The weak growth profiles of these companies highlight structural challenges within the financial sector, which may negatively impact their valuation outlooks as investors favor stocks with visible momentum.
Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Semler, and Cleveland-Cliffs and Encourages Investors to Contact the Firm
Investor Alert: Bragar Eagel & Squire, P.C. is investigating potential claims against Semler Scientific, GoHealth, and Cleveland-Cliffs for possible violations of federal securities laws, encouraging affected investors to contact their attorneys for legal options.
Company Updates: Recent disclosures from Semler regarding a DOJ investigation, a False Claims Act complaint against GoHealth, and Cleveland-Cliffs reporting significant financial losses have led to notable declines in their respective stock prices.
Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Semler, Adtran, and Fulgent and Encourages Investors to Contact the Firm
Investor Alert: Bragar Eagel & Squire, P.C. is investigating potential claims against Semler, GoHealth, Adtran, and Fulgent for possible violations of federal securities laws, encouraging affected investors to contact their attorneys for legal options.
Company-Specific Issues: Each company has faced significant legal challenges, including investigations by the U.S. Department of Justice and issues with financial reporting, leading to notable declines in their stock prices following these disclosures.
GoHealth Reports Disappointing FY Results, Shares Drop
- Disappointing Earnings: GoHealth's FY GAAP EPS of -$20.17 misses expectations by $0.08, indicating significant challenges in profitability that may undermine investor confidence.
- Revenue Decline: The reported revenue of $361.84 million represents a 54.7% year-over-year decline and falls short of the anticipated $437.84 million, highlighting severe pressures on the company's business model that could hinder future growth.
- Stock Price Reaction: Following the earnings report, GoHealth's shares fell 4.65% in after-hours trading, reflecting market disappointment with its financial performance, which may impact the company's future financing capabilities.
- Uncertain Market Outlook: With both revenue and profitability declining, GoHealth may need to reassess its future strategic direction to address challenges posed by intensified industry competition and shifting market demands.
GoHealth (GOCO) Announces Q3 Loss, Falls Short of Revenue Projections
Quarterly Performance: GoHealth reported a quarterly loss of $0.19 per share, significantly better than the expected loss of $2.06, marking a 90.78% earnings surprise. However, revenues of $34.19 million fell short of estimates by 67.05%.
Stock Performance: GoHealth shares have declined approximately 74.3% year-to-date, contrasting with a 16.5% gain in the S&P 500, raising concerns about the company's future stock performance.
Earnings Outlook: The current consensus EPS estimate for the upcoming quarter is $1.92, with revenues projected at $380.13 million. The stock holds a Zacks Rank #3 (Hold), indicating expected performance in line with the market.
Industry Context: The Insurance - Life Insurance industry is currently in the top 20% of Zacks-ranked industries, suggesting that broader industry trends could significantly influence GoHealth's stock performance moving forward.
Brighthouse Financial (BHF) Rises 27.2%: Is There More Growth Potential for the Stock?
Brighthouse Financial Stock Surge: Brighthouse Financial (BHF) shares surged 27.2% to $57.59, driven by acquisition news from Aquarian Holdings and increased trading volume, contrasting with a 2.5% loss over the past month.
Growth and Earnings Outlook: The company is focusing on enhancing its life insurance and annuity products, with expected quarterly earnings of $5.06 per share, reflecting a 26.8% year-over-year increase, and a revenue forecast of $2.25 billion, up 3.3% from last year.
5 Financial Stocks Face Challenges in Growth, Underperforming Compared to Sector Rivals
Weak Growth in Financial Stocks: Several financial sector stocks, including DeFi Technologies Inc., Pathfinder Bancorp Inc., and GoHealth Inc., are struggling with low growth in revenue and earnings, placing them among the weakest performers in their category.
Significant Declines Noted: DeFi Technologies saw a drastic drop in its growth ranking from 62.95 to 9.98, while Pathfinder Bancorp and GoHealth also experienced severe declines, indicating ongoing challenges in sustaining growth.
Performance Overview: Carver Bancorp and LM Funding America showed slight improvements but remain in the lowest growth percentiles, with both companies experiencing significant year-to-date stock price declines.
Investor Implications: The weak growth profiles of these companies highlight structural challenges within the financial sector, which may negatively impact their valuation outlooks as investors favor stocks with visible momentum.
Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Semler, and Cleveland-Cliffs and Encourages Investors to Contact the Firm
Investor Alert: Bragar Eagel & Squire, P.C. is investigating potential claims against Semler Scientific, GoHealth, and Cleveland-Cliffs for possible violations of federal securities laws, encouraging affected investors to contact their attorneys for legal options.
Company Updates: Recent disclosures from Semler regarding a DOJ investigation, a False Claims Act complaint against GoHealth, and Cleveland-Cliffs reporting significant financial losses have led to notable declines in their respective stock prices.
Bragar Eagel & Squire, P.C. Is Investigating GoHealth, Semler, Adtran, and Fulgent and Encourages Investors to Contact the Firm
Investor Alert: Bragar Eagel & Squire, P.C. is investigating potential claims against Semler, GoHealth, Adtran, and Fulgent for possible violations of federal securities laws, encouraging affected investors to contact their attorneys for legal options.
Company-Specific Issues: Each company has faced significant legal challenges, including investigations by the U.S. Department of Justice and issues with financial reporting, leading to notable declines in their stock prices following these disclosures.
